Oppenheimer Asset Management Inc. Conmed Corp Transaction History

Oppenheimer Asset Management Inc.

$7.62 Billion
Q2 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Conmed Corp stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 35,040 shares of CNMD stock, worth $2.36 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

35,040

Previous 27,801 26.04%

Holding current value

$2.36 Million

Previous $2.23 Million 9.07%

% of portfolio

0.03%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$61.9 - $80.36 $448,094 - $581,726	7,239 Added 26.04%	35,040 $2.43 Million
Q1 2024 May 06, 2024	SELL	$75.36 - $112.51 $358,939 - $535,885	-4,763 Reduced 14.63%	27,801 $2.23 Million
Q4 2023 Feb 13, 2024	SELL	$91.3 - $115.05 $74,500 - $93,880	-816 Reduced 2.44%	32,564 $3.57 Million
Q3 2023 Nov 07, 2023	SELL	$97.55 - $135.91 $23,899 - $33,297	-245 Reduced 0.73%	33,380 $3.37 Million
Q2 2023 Aug 02, 2023	SELL	$102.55 - $136.38 $280,166 - $372,590	-2,732 Reduced 7.51%	33,625 $4.57 Million
Q1 2023 May 10, 2023	BUY	$89.75 - $107.27 $390,233 - $466,409	4,348 Added 13.58%	36,357 $3.78 Million
Q4 2022 Feb 06, 2023	SELL	$72.84 - $94.04 $60,675 - $78,335	-833 Reduced 2.54%	32,009 $2.84 Million
Q3 2022 Nov 14, 2022	BUY	$77.78 - $103.92 $60,746 - $81,161	781 Added 2.44%	32,842 $2.63 Million
Q2 2022 Aug 08, 2022	SELL	$88.23 - $154.18 $96,347 - $168,364	-1,092 Reduced 3.29%	32,061 $3.07 Million
Q1 2022 May 12, 2022	SELL	$121.88 - $150.0 $52,652 - $64,800	-432 Reduced 1.29%	33,153 $4.92 Million
Q4 2021 Feb 02, 2022	BUY	$129.86 - $157.03 $244,006 - $295,059	1,879 Added 5.93%	33,585 $4.76 Million
Q3 2021 Nov 12, 2021	BUY	$122.87 - $139.12 $10,935 - $12,381	89 Added 0.28%	31,706 $4.15 Million
Q2 2021 Aug 03, 2021	BUY	$128.08 - $145.09 $168,297 - $190,648	1,314 Added 4.34%	31,617 $4.35 Million
Q1 2021 May 17, 2021	BUY	$111.35 - $130.59 $327,925 - $384,587	2,945 Added 10.76%	30,303 $3.96 Million
Q4 2020 Feb 11, 2021	BUY	$77.7 - $112.82 $349,805 - $507,915	4,502 Added 19.7%	27,358 $3.06 Million
Q3 2020 Nov 13, 2020	BUY	$69.87 - $89.2 $1.6 Million - $2.04 Million	22,856 New	22,856 $1.8 Million
Q1 2020 May 08, 2020	SELL	$39.81 - $112.01 $3,224 - $9,072	-81 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$83.97 - $102.19 $1,343 - $1,635	16 Added 24.62%	81 $8,000
Q2 2019 Aug 09, 2019	BUY	$78.27 - $86.94 $5,087 - $5,651	65 New	65 $6,000
Q3 2018 Oct 26, 2018	SELL	$73.09 - $81.64 $224,167 - $250,389	-3,067 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$61.34 - $76.43 $130,715 - $162,872	-2,131 Reduced 41.0%	3,067 $225,000
Q1 2018 May 09, 2018	BUY	$50.61 - $64.53 $36,034 - $45,945	712 Added 15.87%	5,198 $329,000
Q3 2017 Nov 14, 2017	BUY	$48.38 - $52.52 $217,032 - $235,604	4,486	4,486 $235,000

Others Institutions Holding CNMD

# of Institutions

307

Shares Held

35.5M

Call Options Held

44.6K

Put Options Held

114K

View Full List

About CONMED Corp

Ticker CNMD
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 30,482,400
Market Cap $2.06B
Description
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...

More about CNMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Conmed Corp Transaction History